Dowling & Yahnke’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
Dowling & Yahnke's RMD Position: Q3 2022 in Review
Dowling & Yahnke increased its ResMed (RMD) stake by 0.77% in Q3 2022, buying an estimated $4.1K and bringing the position to 2,358 shares worth $515K. The position accounts for 0.02% of the portfolio, ranked #275.
Dowling & Yahnke first reported a position in RMD in Q4 2017 and has held it in 20 quarters since. The position peaked at $617K in Q3 2021. 668 funds tracked by Wall St. Rank hold RMD as of Q3 2022.
- Dowling & Yahnke held 2,358 shares of ResMed worth $515K as of Q3 2022.
- Dowling & Yahnke bought 18 ResMed shares in Q3 2022, an estimated $4.1K.
- ResMed made up 0.02% of Dowling & Yahnke's portfolio in Q3 2022, its #275 holding.
- Dowling & Yahnke first reported a position in ResMed in Q4 2017 and has held it in 20 quarters since.
- Dowling & Yahnke's ResMed position peaked at $617K in Q3 2021.
- 668 funds tracked by Wall St. Rank held ResMed as of Q3 2022.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.